Evonik Evonik

X

Find the latest Drugs in Development and Pipeline Prospector News of Scohia Pharma.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Scohia Pharma
japan Flag
Country
Country
Japan
Address
Address
Shonan Health Innovation Park, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555
Telephone
Telephone
+81 466-32-1592
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Under the agreement, Kuria may develop, manufacture, and commercialize worldwide the locally delivered formulations of SCO-116, one of SCOHIA’s internally discovered novel Nrf2 activators, for prevention and/or treatment of eye and skin diseases.


Lead Product(s): KTX-101

Therapeutic Area: Ophthalmology Product Name: SCO-116

Highest Development Status: IND EnablingProduct Type: Small molecule

Partner/Sponsor/Collaborator: Kuria Therapeutics

Deal Size: $67.0 million Upfront Cash: Undisclosed

Deal Type: Licensing Agreement June 27, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY